Cognitive behaviour therapy versus specific pharmacological treatments for schizophrenia

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Jones, Christopher ^a   Cormac, Irene ^b   Campbell, Colin ^c   Meaden, Alan ^d   Hacker, David ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b RAMPTON HOSPITAL   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (United Kingdom)

^d BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE THERAPY; HUMAN; REVIEW; SCHIZOPHRENIA;

EID: 70049084203     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007965     Document Type: Review

References (28)

1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. American Psychiatric Association, 1995.
3. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
4. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-411 (Pubitemid 29476240)
5. Christison GW, Kirch DG, Wyatt RJ. When symptoms persist: choosing among alternative somatic symptoms for schizophrenia. Schizophrenia Bulletin 1991;17:217-245
6. Davis JM, Casper R. Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs 1977;14:260-282 (Pubitemid 8170541)
7. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28;Cape Town, South Africa. 2000.
8. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-629
9. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971-2980
10. Drake RE, Cotton PG. Depression, hopelessness and suicide in chronic schizophrenia. British Journal of Psychiatry 1986;148:554.
11. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315:629-634 (Pubitemid 27387172)
12. Elbourne D, Altman DG, Higgins JPT, Curtina F, Worthingtond HV, Vaile A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-149 (Pubitemid 34284916)
13. Gulliford MC. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-883
14. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
15. Higgins JPT, Green S, editors. Cochrane Handbook for systematic reviews of interventions 5.0.1[updated September 2008]. The Cochrane Collaboration 2008.
16. Jones C, Cormac I, Mota J, Campbell C. Cognitive Behaviour Therapy for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD000524.pub2]
17. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987;13:261-276 (Pubitemid 18039085)
18. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. What does the PANSS mean?. Schizophrenia Research 2005;79:231-238
19. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale Scores. British Journal of Psychiatry 2005;187:366-371 (Pubitemid 41442390)
20. Marshall M, Lockwood A, Adams C, Bradley C, Joy C, Fenton M. Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?. British Journal of Psychiatry 2000;176:249-252 (Pubitemid 30179844)
21. Meltzer HY. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophrenia Bulletin 1992;18:515-542
22. National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. NICE guideline. London: National Institute for Clinical Excellence, 2002. [: http://www.nice.org.uk/pdf/CG1NICEguideline.pdf]
23. Overall J, Gorham D. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10:799-812.
24. Tarrier N, Beckett R, Harwood S, Baker A, Yusupoff L, Ugarteburu I. A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome. British Journal of Psychiatry 1993;162:524-532 (Pubitemid 23105926)
25. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1-75. (Pubitemid 29201269)
26. World Health Organisation. Report of the International Pilot Study of Schizophrenia. WHO 1.
27. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, Pinfold V, Takriti Y. The Leeds Outcomes Stakeholders Survey (LOSS) Study. Proceedings of the 15th Cochrane Colloquium; 2007 Oct 23-27; San Paulo. 2007.
28. Jones C, Cormac I, Mota J, Campbell C. Cognitive Behaviour Therapy for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD000524.pub2]